Detalhe da pesquisa
1.
Approaches to Selecting "Time Zero" in External Control Arms with Multiple Potential Entry Points: A Simulation Study of 8 Approaches.
Med Decis Making
; 42(7): 893-905, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35514320
2.
Channeling effects in the prescription of new therapies: the case of emicizumab for hemophilia A.
J Comp Eff Res
; 11(10): 717-728, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35535702
3.
Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States.
Adv Ther
; 39(8): 3678-3695, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35727476
4.
Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study.
J Hematol Oncol
; 15(1): 170, 2022 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36494725
5.
Estimating the risk of thrombotic events in people with congenital hemophilia A using US claims data.
J Comp Eff Res
; 10(18): 1323-1336, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34676773